Neogen Corporation SEC filings document material events for an operating company focused on food safety and animal safety products. Recent 8-K filings cover quarterly results and financial condition, Regulation FD disclosures related to Petrifilm manufacturing validation, and exhibits containing earnings releases and business updates.
The company’s filings also record governance and leadership matters, including executive appointments and departures, compensatory arrangements, board committee assignments, annual meeting voting results, executive compensation votes, and auditor ratification. These disclosures provide formal records of Neogen’s public-company reporting, operating updates, governance structure and shareholder matters.
Neogen Corporation (NEOG) reported an insider transaction by a director. On 10/24/2025, the director acquired 19,386 shares of common stock at a $6.19 price and now holds 19,386 shares directly.
The filing also reports a grant of 49,929 stock options with a $6.19 exercise price, expiring on 10/24/2035. The options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.
Neogen Corp (NEOG) filed a Form 3 for a reporting person serving as a Director. The filing states that no securities are beneficially owned. The event date is 10/24/2025, and the form was filed by one reporting person. The document is signed by Attorney in Fact Christopher Sefcheck on 10/28/2025.
Neogen Corp (NEOG) Form 4: A company director reported transactions dated 10/23/2025. The filer acquired 19,769 shares of common stock at $6.07, bringing directly held shares to 35,084 after the transaction. The filing indicates direct ownership.
The director was also awarded options covering 50,814 shares at an exercise price of $6.07, expiring 10/23/2035. According to the footnote, options and RSUs vest in equal annual installments on each of the first three anniversaries of the grant.
Neogen Corp (NEOG) — Form 4 insider report: A company director reported acquiring 19,769 shares of common stock on 10/23/2025 at $6.07 per share, bringing direct beneficial ownership to 19,769 shares. The filer also received a grant of options for 50,814 shares at a $6.07 exercise price, expiring 10/23/2035. Per the footnote, these awards vest in equal annual installments on each of the first three anniversaries of the grant date.
Neogen (NEOG) filed a Form 4 reporting director equity awards. On 10/23/2025, the reporting person acquired 19,769 shares of common stock at $6.07. Following this, directly held common stock totaled 36,788 shares.
The filing also reports 50,814 stock options granted at an exercise price of $6.07, expiring on 10/23/2035, with 50,814 derivative securities beneficially owned after the transaction. Per the footnote, options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.
Neogen Corporation (NEOG) director reported equity grants. On 10/23/2025, the insider acquired 19,769 shares of common stock at $6.07 per share, bringing direct beneficial ownership to 43,757 shares. The filer also reported a grant of options to buy 50,814 shares at an exercise price of $6.07, expiring on 10/23/2035. According to the footnote, the options and RSUs vest in equal annual installments on each of the first three anniversaries of the grant date.
Neogen Corp (NEOG) reported an insider equity transaction. A director acquired 19,769 shares of common stock at $6.07 on 10/23/2025 (Transaction Code A). Following this, the director beneficially owned 34,621 common shares directly.
The filing also reports a grant of options to purchase 50,814 shares at an exercise price of $6.07, expiring on 10/23/2035. After the transactions, the director held 50,814 options. The options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.
Neogen Corp (NEOG) — Form 4 insider report: A director reported an award on 10/23/2025. The filing shows 19,769 shares of common stock acquired (Code A) at $6.07, bringing direct beneficial ownership to 48,469 shares. The director was also granted options to purchase 50,814 shares at an exercise price of $6.07, expiring 10/23/2035. A footnote states the options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.
Neogen Corp (NEOG) — Form 4 insider activity: A director reported awards dated 10/23/2025. The filing shows an acquisition of 19,769 shares of common stock and a grant of options covering 50,814 shares with a $6.07 exercise price, expiring on 10/23/2035. The form lists 19,769 common shares and 50,814 derivative securities beneficially owned following the transactions, all held directly. Both the options and RSUs vest in equal annual installments on each of the first three anniversaries of the grants.
Neogen (NEOG) reported an insider equity grant by a director on 10/23/2025. The filing shows 50,814 stock options with a $6.07 exercise price expiring on 10/23/2035, and 19,769 shares acquired.
Per the footnote, the options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants. Following these transactions, the director beneficially owned 112,314 shares, held directly.